|
Click HERE to view newer
releases at
June 07
Diversa and Celunol
complete merger to create Verenium Corporation, a leader in the
emerging biofuels industry
May 07
Diversa achieves
milestones under alliance with BASF to develop innovative new
enzyme products
March 07
Diversa reports
financial results for the quarter and year ended December 31,
2006
February 07
Diversa and
Cargill expand collaboration agreement
January 07
Diversa and
Celunol announce merger to create a new biofuels industry leader
Diversa
Corporation joins forces with New Zealand Crown Research
Institutes to develop New Zealand biofuels industry
Syngenta and
Diversa agree on new R&D partnership to discover enzymes for
biofuels
Syngenta und Diversa beschließen neue Partnerschaft zur
Erforschung und Entwicklung von Enzymen für Biotreibstoffe
Syngenta et Diversa concluent un nouveau partenariat de R&D pour
découvrir des enzymes destinées à la production de biocarburants
February 06
BASF and Diversa form
broad alliance to develop innovative new products
January 06
Diversa Corporation
announces reorganization to align operations with more focused business
strategy
October 05
Diversa
Corporation announces departure of its President and Chief Executive
Officer - Edward T. Shonsey to assume role of
CEO
July 04
Syngenta and Diversa
strengthen their collaboration
February 04
Biopharming partnership
moving forward
January 04
Diversa Corporation
achieves 2003 milestones under Syngenta agreements
Cellectis and
Diversa enter into a License Agreement for microorganisms
improvement
June 03
Diversa reports
financial results for the quarter and six months ended June 30, 2003
Diversa
announces issuance of patents directed to discovery and evolution
technologies
May 03
Diversa expands relationship
with DuPont
April 03
Diversa
reports financial results for the quarter ended March 31, 2003
Diversa awarded patent for
Tunable GeneReassembly (TGR) technology
February 03
Diversa and Syngenta
complete transactions announced in December
Diversa Corporation reports financial results for the quarter and year
ended December 31, 2002
January 03
Edward Shonsey joins
Diversa as Senior Vice President, Internal Development
December 02
Diversa Corporation
achieves all 2002 milestones in joint venture with Syngenta
Diversa and BioProspect
sign biodiversity access agreement in Australia
Syngenta and Diversa
form extensive research and product development alliance; Diversa to
acquire rights to Syngenta technology for pharmaceutical applications in
exchange for equity
October 02
Diversa reports financial
results for the quarter and nine months ended September 30, 2002
September 02
Diversa granted first
U.S. patent covering sequencing-based discovery from mixed populations
of environmental genes
January
02
Diversa
reports financial results for quarter and year ended December 31, 2001
December 01
Diversa announces key
management appointments and promotions
October 01
Diversa expands
biodiversity network to include environments in Ghana and Kenya --
Benefit-sharing agreements grant access to biodiversity 'hotspots' in
Africa
September 01
Diversa announces
issuance of patent reinforcing rights for discovery of enzymes from all
of biodiversity
July 01
Diversa exceeds revenue
and earnings expectations for quarter and six months ended June 30, 2001
June 01
Diversa introduces
next-generation gene evolution technology at BIO 2001
January
01
Diversa Corporation
achieves milestone in joint venture with Syngenta; Product candidate and
several leads delivered to newly-named Zymetrics
November
00
Diversa
signs first biodiversity access agreement with Russia
October
00
Diversa
reports financial results for the quarter and nine months ended September 30, 2000
Diversa
expands research collaboration with Novartis into new area - New
project to apply Diversa's evolution technologies to crop protection
chemicals
July
00
Diversa
licenses three performance-enhancing products to Invitrogen - Products
improve polymerase chain reaction; applications in DNA amplification,
genomics research
Diversa
reports financial results for the quarter and six months ended June 30, 2000
February
00
Diversa
announces $200 million initial public offering of common stock
January
00
Diversa
Granted U.S. patent protecting normalized DNA libraries
August 99
Diversa granted a
fundamental U.S. patent for combining natural and "non-natural'' evolution
January 99
Diversa and
Novartis form alliance for crop protection and improvement
|
